Relief Therapeutics Holding AG (RLFTF)

[tcm55]

Trial Info

aviptadil NCT04360096 Not yet recruiting
Inclusion Criteria:

Moderate or Severe COVID-19 by FDA definition with no evidence of Respiratory Failure
Capable of using mesh nebulizer to administer medication with assistance if needed
Exclusion Criteria:

Evidence of Respiratory Failure
Use or impending use of ventilation or high flow nasal oxygen 20L or greater

NCT04311697 recruiting
SOC is defined not to include extracorporeal mechanical oxygenation.